Back to UBS Group AG UBS Group AG

LUNGLUNG
Showing 8 of 23 quarters

Position history for UBS Group AGUBS Group AG's holdings in PULMONX CORP

UBS Group AG holds 204,053 shares of LUNG (PULMONX CORP), worth $265,269 as of 2026-Q2. The position was decreased (-2.7% shares).

Current Value

$265,269

Current Shares

204,053

Total Value Change

+$89,745

Total Shares Change

+182,880

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
204,053
-2.7%
$265,2690.0%$1.30
0
2026-Q1
Increased
209,701
+22.2%
$270,5140.0%$1.53
19
2025-Q4
Increased
171,596
+111.1%
$379,2280.0%$2.28
38
2025-Q3
Decreased
81,292
-70.5%
$131,6930.0%$1.65
0
2025-Q2
Increased
275,895
+232.2%
$714,5680.0%$2.60
40
2025-Q1
Decreased
83,062
-58.9%
$559,0070.0%$6.82
0
2024-Q4
Increased
201,838
+853.3%
$1.4M0.0%$6.71
41
2024-Q3
Decreased
21,173
-6.5%
$175,5240.0%$8.29
0

Other major holders of LUNG: PRIMECAP MANAGEMENT CO/CA/, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used